Tumor-associated macrophages are associated with response to neoadjuvant chemotherapy and poor outcomes in patients with triple-negative breast cancer
Conclusions: our data showed that TAMs may predict chemotherapeutic response and can be used as a promising prognostic candidate for poor survival in TNBC patients treated with NAC.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Jia-hui Ye, Xiao-hua Wang, Jia-jun Shi, Xi Yin, Cheng Chen, Yan Chen, Hong-Yan Wu, Shi Jiong, Qi sun, Meng Zhang, Xian-biao Shi, Guo-ren Zhou, Shahzeb Hassan, Ji-feng Feng, Xin-yun Xu, Wei-jie Zhang Tags: Research Paper Source Type: research
More News: Breast Cancer | Breast Conservation Surgery | Cancer | Cancer & Oncology | Chemotherapy | Mastectomy | Men | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study